PYTHARO

Welcome to the Brand page for “PYTHARO”, which is offered here for In the statement, class 5 has been corrected per the restriction dated august 9, 2018, and per the fnote dated june 3, 2019.;anti-infectives; anti-inflammatories; antibacterial [ pharmaceutical ] * pharmaceuticals * [ preparations ] ; antibiotics; antifungal preparations; antivirals; cardiovascular [ pharmaceutical ] * pharmaceuticals * [ preparations ] ; dermatological pharmaceutical preparations; [ pharmaceutical preparations to be inhaled, for the prevention and treatment of respiratory disorders and diseases; ] * inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; * pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of [ gastrointestinal ] * gastro-intestinal * diseases; pharmaceutical preparations for use the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the [ musculoskeletal ] * musculo-skeletal * system and the [ urogenital ] * genitourinary * system; pharmaceutical preparations [ used ] * for use * in hematology and in [ organ and tissue ] * tissue and organ * transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; [ pharmaceutical preparations for the prevention and treatment of cardiac rhythm disturbances; ] * pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; * [ pharmaceutical preparations for the prevention and treatment of diseases and disorders linked to the immune system; ] * pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; * pharmaceutical preparations for the prevention and treatment of [ renal ] * kidney * diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of [ high blood pressure ] * hypertension * ; pharmaceutical preparations for the prevention and treatment of skin [ diseases ] * disorders * ; pharmaceutical preparations [ used ] * for use * in dermatology; pharmaceutical preparations [ used ] * for use * in urology; [ pharmaceutical preparations used in ophthalmology; ] * pharmaceutical preparations for ophthalmological use; * pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma;.

Its status is currently believed to be active. Its class is unavailable. “PYTHARO” is believed to be currently owned by “NOVARTIS AG”.


Owner:
NOVARTIS AG
Owner Details
Description:
In the Statement, class 5 has been corrected per the Restriction dated August 9, 2018, and per the fnote dated June 3, 2019.;Anti-infectives; anti-inflammatories; antibacterial [ pharmaceutical ] * pharmaceuticals * [ preparations ] ; antibiotics; antifungal preparations; antivirals; cardiovascular [ pharmaceutical ] * pharmaceuticals * [ preparations ] ; dermatological pharmaceutical preparations; [ pharmaceutical preparations to be inhaled, for the prevention and treatment of respiratory disorders and diseases; ] * inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; * pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of [ gastrointestinal ] * gastro-intestinal * diseases; pharmaceutical preparations for use the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the [ musculoskeletal ] * musculo-skeletal * system and the [ urogenital ] * genitourinary * system; pharmaceutical preparations [ used ] * for use * in hematology and in [ organ and tissue ] * tissue and organ * transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; [ pharmaceutical preparations for the prevention and treatment of cardiac rhythm disturbances; ] * pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; * [ pharmaceutical preparations for the prevention and treatment of diseases and disorders linked to the immune system; ] * pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; * pharmaceutical preparations for the prevention and treatment of [ renal ] * kidney * diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of [ high blood pressure ] * hypertension * ; pharmaceutical preparations for the prevention and treatment of skin [ diseases ] * disorders * ; pharmaceutical preparations [ used ] * for use * in dermatology; pharmaceutical preparations [ used ] * for use * in urology; [ pharmaceutical preparations used in ophthalmology; ] * pharmaceutical preparations for ophthalmological use; * pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma;
Categories: STATEMENT